Novartis And UK Launch Partnership On Groundbreaking Cardiovascular Prevention Trial

00:00 EST 12 Feb 2020 | SCRIP

Partnership includes provision for fast-tracked uptake of inclisiran in England, if NICE finds it cost effective

More From BioPortfolio on "Novartis And UK Launch Partnership On Groundbreaking Cardiovascular Prevention Trial"